Exicure (XCUR) Operating Expenses (2016 - 2026)
Exicure (XCUR) reported Operating Expenses of $1.6 million for Q1 2026, up 156.11% on a YoY basis from $640358.0 in Q1 2025, and down 27.3% quarter-over-quarter from $2.3 million in Q4 2025.
Exicure (XCUR) Operating Expenses (2016 - 2026) Analysis & Trends
Exicure has reported Operating Expenses for 11 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 156.11% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.8 million (up 3.81% YoY), and the FY2025 full-year result was $4.2 million, down 66.75% from the prior year.
- Operating Expenses for Q1 2026 stood at $1.6 million, down from $2.3 million in the prior quarter.
- The five-year high for Operating Expenses was $10.3 million in Q1 2022, with the low at -$2.9 million in Q1 2025.
- Historically, Operating Expenses has averaged $3.8 million across 5 years, with a median of $2.6 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Expenses jumped 406.61% — and 2025, when it tumbled 318.79%.
- Exicure's Operating Expenses stood at $3.2 million in 2022, then sank by 52.89% to $1.5 million in 2023, then jumped by 406.61% to $7.6 million in 2024, then slumped by 70.27% to $2.3 million in 2025, then decreased by 27.3% to $1.6 million in 2026.
- The last three Operating Expenses figures came in at $1.6 million (Q1 2026), $2.3 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -67.40 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 2.51 Mn |
| Mar 31, 2025 | -2.92 Mn |
| Dec 31, 2024 | 7.59 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 3.32 Mn |
| Jun 30, 2023 | 5.64 Mn |
| Mar 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 3.18 Mn |
| Sep 30, 2022 | 7.22 Mn |
| Jun 30, 2022 | 9.95 Mn |
| Mar 31, 2022 | 10.30 Mn |
| Dec 31, 2021 | 15.57 Mn |
| Sep 30, 2021 | 19.40 Mn |
| Jun 30, 2021 | 13.94 Mn |